Episode Details

MicroJect, a startup backed by UCD researchers, is revolutionizing medicine administration with their polymer microneedle technology. This innovation aims to reduce production costs, enable self-administration, and improve patient care, particularly in allergy testing. Their first product is set to launch in early 2028, initially targeting the UK and Europe, with global expansion planned for the following years. The challenge lies in scaling up production and integrating their solution into healthcare practices.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/4db2fa5bf6035d17